Stock Research: Faes Farma,

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Faes Farma,

BME:FAE ES0134950F36
84
  • Value
    98
  • Growth
    39
  • Safety
    Safety
    79
  • Combined
    92
  • Sentiment
    29
  • 360° View
    360° View
    84
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Faes Farma SA is a Spain-based pharmaceutical company that researches, produces, distributes, and sells drugs, supplements, and personal care treatments, as well as raw materials. Key businesses include prescription and generic drugs, OTC medicines, food supplements, personal care, and animal nutrition products. The company operates in Spain, Portugal, Chile, and Mexico. In the last fiscal year, the company had 1775 employees, a market cap of $1676 million, profits of $338 million, and revenue of $511 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 84 (better than 84% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Faes Farma, are very positive. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Faes Farma,. The consolidated Value Rank has an attractive rank of 79, which means that the share price of Faes Farma, is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 79% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 98. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 29. Professional investors are more confident in 71% other stocks. The consolidated Growth Rank also has a low rank of 39, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 61 of its competitors have better growth. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
79 86 89 98
Growth
39 35 5 9
Safety
Safety
98 93 94 92
Sentiment
29 85 38 32
360° View
360° View
84 93 70 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 5 11 31
Opinions Change
50 72 50 23
Pro Holdings
n/a 100 100 78
Market Pulse
7 84 31 35
Sentiment
29 85 38 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
79 86 89 98
Growth
39 35 5 9
Safety Safety
98 93 94 92
Combined
92 87 78 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
74 72 78 85
Price vs. Earnings (P/E)
38 45 63 77
Price vs. Book (P/B)
64 61 76 71
Dividend Yield
77 91 86 96
Value
79 86 89 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
81 23 16 10
Profit Growth
19 45 48 41
Capital Growth
1 27 1 16
Stock Returns
71 79 38 46
Growth
39 35 5 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
92 87 80 79
Refinancing
67 52 73 72
Liquidity
94 92 98 96
Safety Safety
98 93 94 92

Similar Stocks

Discover high‑ranked alternatives to Faes Farma, and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.